Rene Westhovens Selected Research

Abatacept (Orencia)

1/2018	Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study.
6/2015	Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE).
5/2015	Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.
3/2015	Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis.
7/2014	Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended study.
6/2014	Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.
6/2013	Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program.
11/2011	Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
10/2011	Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial.
3/2011	Improvements in participation in usual daily activities in patients with rheumatoid arthritis treated with abatacept.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rene Westhovens Research Topics

Disease

48	Rheumatoid Arthritis 03/2024 - 02/2002
8	Pain (Aches) 03/2024 - 04/2008
8	Systemic Scleroderma (Systemic Sclerosis) 08/2019 - 01/2010
5	Fatigue 01/2021 - 04/2008
3	Neoplasms (Cancer) 10/2015 - 06/2013
3	Infections 06/2013 - 04/2006
2	Inflammation (Inflammations) 01/2022 - 08/2010
2	Axial Spondyloarthritis 01/2021 - 01/2016
2	Rheumatic Diseases (Rheumatism) 08/2019 - 06/2015
2	Chronic Disease (Chronic Diseases) 01/2018 - 06/2014
2	Arthralgia (Joint Pain) 07/2008 - 07/2007
2	Breast Neoplasms (Breast Cancer) 07/2008 - 07/2007
2	Body Weight (Weight, Body) 06/2006 - 11/2003
1	Herpes Zoster 01/2023
1	Necrosis 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Asthenopia (Eyestrain) 01/2021
1	Mobility Limitation (Difficulty Walking) 01/2021
1	Kinesiophobia 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2019
1	Atherosclerosis 01/2019
1	Joint Diseases (Joint Disease) 03/2017
1	Osteoarthritis 10/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2015
1	Antisynthetase syndrome 04/2015
1	Hemophilia A (Haemophilia) 01/2015
1	of childhood progressive pseudorheumatoid Arthropathy 01/2015
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 06/2014
1	Weight Loss (Weight Reduction) 11/2013
1	Fever (Fevers) 11/2013
1	Arthritis (Polyarthritis) 08/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Chronic Pain 08/2010
1	Sarcoidosis (Schaumann Disease) 11/2007
1	Dyspnea (Shortness of Breath) 11/2007
1	Erythema Nodosum 11/2007
1	Cough 11/2007

Drug/Important Bio-Agent (IBA)

20	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 02/2002
16	Abatacept (Orencia)FDA Link 01/2018 - 06/2006
6	GlucocorticoidsIBA 01/2023 - 04/2015
6	Infliximab (Remicade)FDA Link 08/2010 - 01/2005
5	ametantrone (HAQ)IBA 01/2021 - 04/2008
4	Rituximab (Mabthera)FDA Link 08/2019 - 01/2010
4	golimumab FDA Link 12/2015 - 03/2013
3	GLPG0634IBA 03/2024 - 01/2018
3	C-Reactive ProteinIBA 03/2024 - 03/2017
3	Rheumatoid FactorIBA 01/2018 - 11/2007
2	CT-P13IBA 01/2022 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 02/2002
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2002
2	amsonic acid (DAS)IBA 01/2019 - 03/2015
2	Antirheumatic Agents (DMARD)IBA 03/2017 - 10/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014 - 09/2008
2	AutoantibodiesIBA 11/2012 - 01/2011
2	Aromatase InhibitorsIBA 07/2008 - 07/2007
1	Adalimumab (Humira)FDA Link 03/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	LipidsIBA 01/2023
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	DEPOIBA 01/2022
1	Leflunomide (Arava)FDA LinkGeneric 01/2020
1	Certolizumab Pegol FDA Link 10/2019
1	SolventsIBA 07/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2018
1	Anti-Citrullinated Protein AntibodiesIBA 01/2018
1	Biosimilar PharmaceuticalsIBA 10/2017
1	phytobacteriomycin (PBM)IBA 01/2016
1	Tumor Necrosis Factor InhibitorsIBA 10/2015
1	TESIBA 06/2015
1	Tuberculin (PPD)IBA 01/2015
1	chemotactic factor inactivatorIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2014
1	Collagen ReceptorsIBA 09/2013
1	Glycoproteins (Glycoprotein)IBA 09/2013
1	Analgesics (Analgesic Drugs)IBA 08/2012
1	Genetic Markers (Genetic Marker)IBA 07/2011
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	anticentromere antibodyIBA 01/2010
1	Tamoxifen FDA LinkGeneric 07/2008
1	Etanercept (Enbrel)FDA Link 11/2007
1	exemestane (Aromasin)FDA Link 07/2007

Therapy/Procedure

17	Therapeutics 01/2022 - 02/2002
3	Intravenous Infusions 01/2010 - 01/2005
2	Remission Induction 01/2020 - 03/2017
1	Biological Therapy 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2021
1	Activities of Daily Living (ADL) 01/2021
1	Heart Transplantation (Grafting, Heart) 06/2018
1	Drug Tapering 03/2015
1	Stem Cell Transplantation 01/2015
1	Aftercare (After-Treatment) 06/2014
1	Hematopoietic Stem Cell Transplantation 06/2014
1	Pain Management 08/2012
1	Drug Therapy (Chemotherapy) 08/2012
1	Retreatment 01/2010